The yeast homolog, TMA108, has been studied for its unique role in translation:
Ribosome Association: TMA108 interacts with nascent peptides of specific mRNAs (e.g., ATP2, ASN1) encoding ATP/Zinc-binding proteins, influencing their translation and localization .
Catalytic Role: Structural modeling suggests TMA108 functions as an M1 metallopeptidase, binding nascent polypeptides via a catalytic pocket .
mRNA Localization: Deletion of TMA108 disrupts mitochondrial localization of ATP2 mRNA, highlighting its role in spatial regulation of translation .
Human TMEM108 is implicated in:
Neuronal Development: Required for AMPA receptor surface expression and excitatory neurotransmission in dentate granule neurons .
Axonal Transport: Mediates retrograde transport by linking dynein/dynactin motor complexes to vesicle cargos via DST interaction .
BDNF Signaling: Facilitates BDNF-dependent dendrite outgrowth and actin-dependent trafficking of NTRK2 receptors .
The ab229087 antibody is ideal for:
Western Blot: Detects TMEM108 in human lysates to study its expression in neuronal or developmental contexts.
Research Models: Used in studies linking TMEM108 to neurodegenerative diseases or synaptic plasticity .
Homology Confusion: The antibody targets human TMEM108, not yeast TMA108, necessitating clarification in cross-species studies .
Mechanistic Insights: Further studies are needed to explore TMEM108’s enzymatic activity (akin to yeast TMA108) in human systems .
KEGG: sce:YIL137C
STRING: 4932.YIL137C
Tma108 is a translation machinery-associated factor in Saccharomyces cerevisiae (baker's yeast) that challenges the traditional assumption that translation relies on standardized molecular machinery. It represents a specialized factor that associates with a specific subset of ribosomes involved in translating mRNAs encoding proteins with ATP or Zinc binding domains .
The significance of Tma108 lies in its high selectivity for specific nascent peptide chains, making it a unique example of a translation-associated factor that goes beyond the general RNA binding proteins. Research has demonstrated that Tma108 directly interacts with nascent protein chains during translation, suggesting it plays a role in co-translational regulation of specific mRNAs .
Tma108 is particularly important for understanding specialized translation mechanisms as it illustrates the existence of specific translation-associated factors that may regulate translation in ways previously unrecognized. Its study provides insights into how cells might control the translation of specific subsets of mRNAs through specialized ribosome-associated factors .
Tma108 interacts with mature mRNA-ribosome complexes during active translation. This interaction was confirmed through immunoprecipitation experiments conducted under conditions that maintained ribonucleoprotein (RNP) structures . Mass spectrometry analysis of proteins co-immunoprecipitated with Tma108 revealed that more than 80% were known components of the translation machinery, including core members of the 60S and 40S ribosomal subunits and general translation factors .
The interaction between Tma108 and ribosomes appears to be dependent on intact ribosome structure, as EDTA treatment, which dissociates the 40S and 60S subunits, abolished all these interactions. This indicates that Tma108 likely interacts with fully assembled ribosomes during translation rather than with individual subunits .
Importantly, ribonucleoparticle dissociation experiments established that Tma108 directly interacts with the nascent protein chain rather than with the mRNA or ribosomal components themselves. This was further confirmed by demonstrating that translation of the first 35 amino acids of Asn1, one of Tma108's targets, is necessary and sufficient to recruit Tma108 to the translation machinery, suggesting it is loaded early during translation .
Tma108 shows remarkable selectivity, targeting less than 200 specific mRNAs out of the entire yeast transcriptome. Analysis revealed that these target mRNAs predominantly encode proteins with ATP-binding, RNA-binding, or Zinc-binding domains .
Interestingly, while Tma108 affects the localization of ATP2 mRNA to mitochondria, gene ontology enrichment analyses showed that Tma108 targets were not specifically enriched for mRNAs encoding mitochondrial proteins. Instead, the common feature appears to be the presence of specific domains in the encoded proteins .
The selective recognition of these mRNAs by Tma108 seems to be mediated through the nascent peptide features rather than through direct mRNA binding. This was demonstrated through molecular dissection of the signals involved in Tma108's selective recognition of ATP2 and ASN1 mRNAs, which revealed the crucial role of the first translated amino acids in recruiting Tma108 to the translational machinery .
Several sophisticated experimental approaches can be employed to detect and characterize TMA108-nascent chain interactions. One effective approach is immunoprecipitation of ribonucleoprotein particles under conditions that preserve the integrity of translation complexes. In the study by researchers, proteinA-tagged Tma108 was immunoprecipitated in buffer conditions (20 mM Hepes pH 7.5, 110 mM KOAc, 2 mM MgCl2) that maintained ribonucleoprotein structures .
Mass spectrometry analysis of co-immunoprecipitated proteins provides valuable information about the components of the translation machinery that associate with Tma108. This approach revealed that over 80% of proteins co-purified with Tma108 were translation machinery components, including ribosomal proteins and translation factors .
For detecting the specific mRNAs associated with Tma108, researchers can use real-time quantitative PCR on the RNA extracted from Tma108 immunoprecipitates. This technique allowed researchers to identify a clear enrichment of specific mRNAs in Tma108 immunoprecipitates .
To establish that Tma108 directly interacts with nascent chains rather than with mRNA or ribosomal components, EDTA treatment can be used to dissociate ribosomes, followed by immunoprecipitation. The loss of interactions after EDTA treatment indicates dependence on intact ribosome structure. Additional controls using RNase treatment can help distinguish between RNA-mediated and protein-mediated interactions .
TMA108 antibodies provide a powerful tool for investigating co-translational mRNA localization phenomena. Researchers can employ fluorescence in situ hybridization (FISH) in combination with immunofluorescence using TMA108 antibodies to simultaneously visualize both the target mRNAs and Tma108 protein localization within cells .
For quantitative analysis of mRNA localization in large cell populations, researchers can use three-dimensional imaging analysis software like CORSEN. This approach allows for the segmentation and extraction of object features (coordinates and intensity), measurement of distances between mRNA particles and cellular structures (like mitochondria), and statistical analysis of the generated data .
When studying the impact of Tma108 on mRNA localization, comparative analyses between wild-type and Tma108-deficient cells (tma108Δ/Δ) can reveal significant changes in localization patterns. For instance, researchers demonstrated that deletion of TMA108 led to a significant change in ATP2 mRNA localization compared to wild-type strains, with the median ATP2 mRNA-mitochondria distance shifting from 195 to -50 nm in the absence of Tma108 .
For genome-wide analyses of mRNA localization changes, researchers can perform comparative global analyses of mRNAs co-purified with specific cellular fractions (such as mitochondria) in the presence or absence of Tma108 using DNA microarrays. This approach allows for the identification of mRNAs whose localization is specifically impacted by Tma108 activity .
The structural basis for TMA108's selective binding to nascent chains lies in its unique characteristics as an M1 metallopeptidase. Comparative genomic analyses, molecular modeling, and directed mutagenesis have identified Tma108 as an original member of the M1 metallopeptidase family .
Molecular modeling of Tma108's tertiary structure was predicted using the Modeller program interfaced with the HHpred server. The protein sequence was queried against the pdb70 database to retrieve homologous sequences with known structures. The best templates identified were human aminopeptidase A and porcine aminopeptidase N, both covering the entire protein (residues 4-944) with 20% sequence identity .
The quality of the structural model was evaluated with Procheck, which found 85% of the residues in the most favored regions of the Ramachandran plot, indicating reasonable quality of the model .
A critical finding was that Tma108 appears to use its putative catalytic peptide-binding pocket to bind the N-terminus of its targets. This was demonstrated through a single amino acid substitution in the MAMEN motif (E296Q), which showed the involvement of the putative M1 metallopeptidase peptide-binding pocket in Tma108 substrate recognition .
The researchers proposed a model in which the Tma108 catalytic pocket has evolved to recognize specific nascent peptides and participate in the co-translational control of gene expression. This suggests that rather than functioning primarily as an enzyme, Tma108 may have adapted its peptide-binding capability for a regulatory role during translation .
To analyze TMA108's impact on transcriptome-wide mRNA association patterns, researchers employ sophisticated microarray and bioinformatics approaches. For analyzing ribosome-associated mRNAs, microarray hybridizations are performed using cDNA reverse-transcribed from immunoprecipitation samples and the corresponding input samples .
Statistical algorithms like LIMMA are used to determine the list of mRNAs specifically enriched in Tma108 immunoprecipitations compared to control samples (such as Rpl16A immunoprecipitations). Only mRNAs with log2 ratios superior to 0.8 and an adjusted P-value of <0.05 are typically included in the final list of significantly associated transcripts .
For category enrichment analysis, researchers utilize R software along with databases such as Gene Ontology (GO) and Pfam. This allows for the identification of common functional or structural characteristics among the proteins encoded by Tma108-associated mRNAs .
When studying the impact of Tma108 on mRNA localization patterns, comparative global analyses of mRNAs co-purified with specific cellular fractions (such as mitochondria) in wild-type versus tma108Δ/Δ strains can be performed. Again, the LIMMA algorithm is used to detect significant changes (P-value<0.05) in mRNA association with specific cellular compartments .
These comprehensive approaches allowed researchers to identify that Tma108 targets were enriched for mRNAs encoding proteins with ATP-binding, RNA-binding, or Zinc-binding domains, rather than being enriched for any particular cellular localization pattern .
When designing immunoprecipitation experiments with TMA108 antibodies, several essential controls should be included to ensure reliable and interpretable results. First, a mock immunoprecipitation control using either non-specific IgG or an untagged strain (if using tagged Tma108) is crucial to identify non-specific binding .
Researchers should also include controls for ribonucleoprotein complex integrity. EDTA treatment, which dissociates ribosomes into 40S and 60S subunits, serves as an important control to demonstrate the dependence of interactions on intact ribosome structure. In the case of Tma108, all interactions with ribosomal proteins and mRNAs were lost upon EDTA treatment, confirming that Tma108 interacts with mature mRNA-ribosome complexes .
For experiments investigating the specificity of Tma108 for certain mRNAs, immunoprecipitation of general ribosomal proteins (such as Rpl16A) provides a valuable comparative control. This allows researchers to distinguish mRNAs specifically enriched in Tma108 immunoprecipitations from those generally associated with ribosomes .
When analyzing the protein components of immunoprecipitated complexes, mass spectrometry analysis of both Tma108 immunoprecipitates and control immunoprecipitates enables the identification of proteins specifically associated with Tma108. Confirmation of key interactions by immunoblotting of specific proteins (such as Rpl1 and Rpl3) provides additional validation .
Validating the specificity of TMA108 antibodies for immunofluorescence studies requires multiple complementary approaches. First and foremost, researchers should compare immunofluorescence signals between wild-type cells and tma108Δ/Δ deletion mutants. The absence of signal in deletion mutants confirms antibody specificity .
For tagged versions of Tma108 (such as proteinA-tagged Tma108), researchers can perform parallel immunofluorescence experiments using antibodies against the tag and against Tma108 itself. Co-localization of signals provides strong evidence for antibody specificity .
Functional complementation experiments offer another validation approach. If the immunofluorescence pattern is restored in tma108Δ/Δ cells complemented with a plasmid expressing Tma108, this supports antibody specificity. Researchers have confirmed the impact of Tma108 on ATP2 mRNA localization through such functional complementation experiments .
Pre-absorption controls, where the antibody is pre-incubated with purified Tma108 protein before immunofluorescence, can further validate specificity. Significant reduction in signal after pre-absorption indicates specific recognition of Tma108 .
When studying the co-localization of Tma108 with specific mRNAs or cellular structures, appropriate controls for the other fluorescent probes must also be included. For instance, when analyzing the localization of ATP2 mRNA relative to mitochondria, researchers used fluorescent probes for ATP2 mRNA in combination with probes directed against mitochondrial rRNA as markers for mitochondrial position .
Interpreting changes in TMA108 localization patterns requires careful consideration of multiple factors. Researchers should first establish the normal localization pattern of Tma108 in wild-type cells under standard conditions. Any deviation from this baseline pattern in response to experimental manipulations needs to be quantified using appropriate image analysis tools .
When analyzing co-localization with cellular structures or mRNAs, statistical approaches that account for three-dimensional spatial distribution are essential. Software like CORSEN allows for the quantification of distances between Tma108, mRNAs, and cellular structures in large cell populations (>100 cells per condition), providing robust statistical analyses of relative localization patterns .
Changes in Tma108 localization may reflect alterations in its association with the translation machinery. Since Tma108 interacts with ribosomes during translation of specific mRNAs, changes in its localization could indicate shifts in the translation sites of its target mRNAs. This interpretation is supported by the observation that Tma108 inactivation led to a drastic change in the subcellular localization of ATP2 mRNA .
Researchers should also consider the potential impact of experimental conditions on translation dynamics. Since Tma108 associates with actively translating ribosomes, treatments that affect translation (such as cycloheximide or puromycin) may significantly alter its localization pattern. Appropriate controls for such effects are essential for accurate interpretation .
Several factors can contribute to false positive or negative results when using TMA108 antibodies in research applications. Cross-reactivity with related proteins represents a significant potential source of false positives, particularly given that Tma108 belongs to the M1 aminopeptidase family. In yeast, the closest paralogs of Tma108 are Aap1 and Ape2, which could potentially be recognized by antibodies raised against conserved regions of these proteins .
Fixation and permeabilization conditions can dramatically impact antibody accessibility and epitope preservation, potentially leading to false negatives if Tma108 epitopes are masked or denatured. Researchers should optimize these conditions specifically for Tma108 detection .
The transient nature of Tma108's association with nascent chains during translation may result in false negatives if samples are not properly prepared to capture these interactions. Since Tma108 interacts with ribosomes in an EDTA-sensitive manner, maintaining appropriate buffer conditions (including Mg2+ concentration) is crucial for preserving these interactions .
Over-expression of tagged Tma108 for detection purposes might perturb its normal function and localization, as observed in studies where Tma108 over-expression led to a significant decrease in ATP2 mRNA mitochondrial localization. Researchers should be cautious about interpreting results from over-expression systems and validate findings with endogenous protein whenever possible .
Finally, the background genetic context of the yeast strain used can influence Tma108 function and interactions. Experiments should be conducted in well-characterized genetic backgrounds, and comparative analyses between different strains should account for potential genetic variations that might affect Tma108 behavior .
TMA108 antibodies hold significant potential for advancing our understanding of specialized ribosome populations in eukaryotic cells. As Tma108 defines a subpopulation of cellular ribosomes specifically involved in the translation of less than 200 mRNAs with distinctive characteristics, antibodies against this protein can serve as valuable tools for isolating and characterizing these specialized ribosomes .
Researchers could employ TMA108 antibodies in combination with ribosome profiling techniques to obtain detailed, genome-wide information about the exact mRNAs being translated by Tma108-associated ribosomes at single-nucleotide resolution. This approach would provide insights into whether these specialized ribosomes exhibit unique translation dynamics, such as altered elongation rates or specialized handling of certain codon combinations .
Immunoprecipitation with TMA108 antibodies followed by mass spectrometry could reveal whether Tma108-associated ribosomes contain unique compositions of ribosomal proteins or post-translational modifications that distinguish them from the general ribosome population. This would contribute to the emerging concept of "specialized ribosomes" with distinct compositional and functional properties .
Multi-color super-resolution microscopy using TMA108 antibodies in combination with markers for different ribosomal proteins could help visualize the spatial organization of Tma108-associated ribosomes within cells. This might reveal whether these specialized ribosomes occupy distinct subcellular territories correlated with the localization of their target mRNAs .
Comparative studies between TMA108 and other nascent chain-associated factors would significantly enhance our understanding of co-translational regulation mechanisms. Researchers could conduct parallel immunoprecipitation experiments with antibodies against Tma108 and other factors that interact with nascent chains, such as the signal recognition particle (SRP), nascent polypeptide-associated complex (NAC), or chaperones like Ssb1/2 .
Analyzing the overlap and distinctions between the mRNA targets of different nascent chain-associated factors would reveal whether these factors operate in cooperative, competitive, or entirely separate pathways. This could be achieved through comparative microarray or RNA-seq analyses of immunoprecipitated mRNAs .
Structural studies comparing the binding interfaces of Tma108 with those of other nascent chain-binding factors would provide insights into the molecular mechanisms of nascent chain recognition. Since Tma108 appears to use its M1 metallopeptidase peptide-binding pocket for substrate recognition, it represents a unique case of functional repurposing that could be compared with the binding strategies of other factors .
Genetic interaction studies between TMA108 and genes encoding other nascent chain-associated factors would help elucidate functional relationships. Synthetic genetic array analysis with tma108Δ mutants could identify factors that function in parallel or redundant pathways .
Kinetic studies comparing the timing of recruitment of Tma108 versus other factors during translation would be particularly informative. Since Tma108 appears to be recruited early during translation (after the first 35 amino acids of its targets are synthesized), understanding its temporal relationship with other co-translational processes would provide insights into the choreography of co-translational events .